Altta yatan metabolik durumun detayl olarak deerlendirilmesi gerekir
The short version: Melanotan I (Afamelanotide) has received FDA/EMA approval for a specific medical condition (erythropoietic protoporphyria) and is more selective for skin pigmentation
Includes hyaluronic acid, alpha-lipoic acid, and resveratrol for comprehensive benefits
Conflicto de intereses NV ha recibido honorarios por conferencias o financiacin para la asistencia de congresos y cursos de de Novo-Nordisk, Lilly y Boeringher Ingelheim
Pablo de la Cueva has participated as consultant and/or investigator and/or speaker for the following pharmaceutical companies: Abbvie, Almirall, BMS, Boehringer-Ingelheim, Celgene, Janssen Cilag, LEO Pharma, Lilly, MSD, Novartis, Novo Nordisk, Pfizer, Roche, Sanofi, and UCB